193 related articles for article (PubMed ID: 29503155)
1. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
3. Criteria for early identification of aceruloplasminemia.
Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
[TBL] [Abstract][Full Text] [Related]
4. [Aceruloplasminemia, a rare condition not to be overlooked].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
[TBL] [Abstract][Full Text] [Related]
5. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
[TBL] [Abstract][Full Text] [Related]
6. Aceruloplasminemia: Waiting for an Efficient Therapy.
Piperno A; Alessio M
Front Neurosci; 2018; 12():903. PubMed ID: 30568573
[TBL] [Abstract][Full Text] [Related]
7. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.
Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A
Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721
[TBL] [Abstract][Full Text] [Related]
8. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
[TBL] [Abstract][Full Text] [Related]
9. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of heterozygosis for aceruloplasminemia.
Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
[TBL] [Abstract][Full Text] [Related]
11. Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.
Vroegindeweij LHP; Boon AJW; Wilson JHP; Langendonk JG
Orphanet J Rare Dis; 2020 Apr; 15(1):105. PubMed ID: 32334607
[TBL] [Abstract][Full Text] [Related]
12. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
[No Abstract] [Full Text] [Related]
13. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
Parks NE; Vandorpe RA; Moeller JJ
Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
[TBL] [Abstract][Full Text] [Related]
14. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
[No Abstract] [Full Text] [Related]
15. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
16. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
[TBL] [Abstract][Full Text] [Related]
17. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.
Poli L; Alberici A; Buzzi P; Marchina E; Lanari A; Arosio C; Ciccone A; Semeraro F; Gasparotti R; Padovani A; Borroni B
Neurol Sci; 2017 Feb; 38(2):357-360. PubMed ID: 27817091
[TBL] [Abstract][Full Text] [Related]
18. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.
Ondrejkovičová M; Dražilová S; Drakulová M; Siles JL; Zemjarová Mezenská R; Jungová P; Fabián M; Rychlý B; Žigrai M
BMC Gastroenterol; 2020 Apr; 20(1):95. PubMed ID: 32264837
[TBL] [Abstract][Full Text] [Related]
19. Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.
Watanabe M; Ohyama K; Suzuki M; Nosaki Y; Hara T; Iwai K; Kono S; Miyajima H; Mokuno K
Intern Med; 2018 Sep; 57(18):2713-2718. PubMed ID: 29709961
[TBL] [Abstract][Full Text] [Related]
20. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
Kenawi M; Rouger E; Island ML; Leroyer P; Robin F; Rémy S; Tesson L; Anegon I; Nay K; Derbré F; Brissot P; Ropert M; Cavey T; Loréal O
FASEB J; 2019 Dec; 33(12):13492-13502. PubMed ID: 31560858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
